Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: An updated meta-analysis

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6405-6414

  Ge, Yu Zheng ^a   Wang, Yi Dan ^a   Xu, Zheng ^a   Xu, Lu Wei ^a   Wang, Ya Ping ^a   Gu, Mao Hong ^a   Ding, Ai Xing ^a   Zhu, Xian Bo ^a   Wu, Ran ^a   Li, Wen Cheng ^a   Xu, You Di ^a   Jia, Rui Peng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Interferon gamma; Meta analysis; Polymorphism

Indexed keywords

GAMMA INTERFERON;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; ETHNICITY; GAMMA INTERFERON GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; PRIORITY JOURNAL;

ALLELES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; NEOPLASMS; RISK FACTORS;

EID: 84905004179     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1861-9     Document Type: Article

References (61)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.
3. Jin P, Panelli MC, Marincola FM, Wang E. Cytokine polymorphism and its possible impact on cancer. Immunol Res. 2004;30(2):181-90. (Pubitemid 39425341)
4. Howell WM, Rose-Zerilli MJ. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr. 2007;137(1 Suppl):194S-9S. (Pubitemid 46052880)
5. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163-89. (Pubitemid 38174573)
6. Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 2009;20(2):97-113.
7. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41-101. (Pubitemid 350018717)
8. Zaidi MR, Merlino G. The two faces of interferon-gamma in cancer. Clin Cancer Res. 2011;17(19):6118-24.
9. Bekisz J, Sato Y, Johnson C, Husain SR, Puri RK, Zoon KC. Immunomodulatory effects of interferons in malignancies. J Interferon Cytokine Res. 2013;33(4):154-61.
10. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphismin the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol. 2000;61(9):863-6.
11. Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation. 2005;80(12):1773-82. (Pubitemid 43054004)
12. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet. 2003;361(9372):1871-2. (Pubitemid 36645185)
13. Skerrett DL, Moore EM, Bernstein DS, Vahdat L. Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse. Cancer Invest. 2005;23(3):208-14. (Pubitemid 40770738)
14. Kamali-Sarvestani E, Merat A, Talei AR. Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett. 2005;223(1):113-9. (Pubitemid 40693715)
15. Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, et al. Cytokine gene polymorphisms and breast cancer susceptibility. Ann N YAcad Sci. 2006;1089:104-9. (Pubitemid 47092072)
16. Gonullu G, Basturk B, Evrensel T, Oral B, Gozkaman A, Manavoglu O. Association of breast cancer and cytokine gene polymorphism in Turkish women. Saudi Med J. 2007;28(11):1728-33. (Pubitemid 350244364)
17. Karakus N, Kara N, Ulusoy AN, Ozaslan C, Bek Y. Tumor necrosis factor alpha and beta and interferon gamma gene polymorphisms in Turkish breast cancer patients. DNA Cell Biol. 2011;30(6):371-7.
18. Wu G, Zhang J, Lu P. Association of single nucleotide polymorphism of interferon-gamma gene +874 site and breast cancer. Zhong Liu Fang Zhi Za Zhi. 2008;35(9):651-70.
19. Govan VA, Carrara HR, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog. 2003;2(1):3.
20. Guzman VB, Yambartsev A, Goncalves-Primo A, Silva ID, Carvalho CR, Ribalta JC, et al. New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet. 2008;17(12):1838-44. (Pubitemid 351791511)
21. Gangwar R, Pandey S, Mittal RD. Association of interferon-gamma +874A polymorphism with the risk of developing cervical cancer in north-Indian population. BJOG. 2009;116(12):1671-7.
22. Ivansson EL, Juko-Pecirep I, Gyllensten UB. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol. 2010;116(3):544-8.
23. Wang Q, Zhang C, Walayat S, Chen HW, Wang Y. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):330-3.
24. do Carmo Vasconcelos de Carvalho V, de Macedo JL, de Lima CA, da Conceicao Gomes de Lima M, de Andrade Heraclio S, Amorim M, et al. IFN-gamma and IL-12B polymorphisms in women with cervical intraepithellial neoplasia caused by human papillomavirus. Mol Biol Rep. 2012;39(7):7627-34.
25. Kordi Tamandani MK, Sobti RC, Shekari M, Mukesh M, Suri V. Expression and polimorphism of IFN-gamma gene in patients with cervical cancer. Exp Oncol. 2008;30(3):224-9.
26. Wu G, Zhang J, Zuo W. Association between single nucleotide polymorphism of interferon-gamma gene +874 site and susceptibility to ovarian cancer. Journal of Jilin University Medicine Edition. 2009;35(3):507-10.
27. Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, et al. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet. 2005;32(3):167-71. (Pubitemid 40768933)
28. Nearman ZP, Wlodarski M, Jankowska AM, Howe E, Narvaez Y, Ball E, et al. Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias. Br J Haematol. 2007;136(2):237-48. (Pubitemid 46020751)
29. Urbanowicz I, Mazur G, Stacherzak-Pawlik J, Bogunia-Kubik K, Wrobel T, Wozniak M, et al. IFN gamma gene polymorphism may contribute to the susceptibility to CLL. Pathol Oncol Res. 2010;16(2):213-6.
30. Basturk B, Evke E, Tunali A, Karakus S. Interleukin-10 and interferon-gamma cytokine gene polymorphisms may be risk factors for chronicmyelogenous leukemia. Turkish Journal of Haematology. 2005;22(4):191-6.
31. Basturk B, Evke E, Karakus S, Tunali A. Potential risk factor of interleukin-10 gene polymorphism in acute myelogenous leukemia. UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi. 2005;15(2):57-62.
32. Li J, Cao F, Tang H, Liu X, Zhou J. Study on plasma IFN-gamma expression levels and IFN-gamma polymorphism in patients with acute promyeiocyti leukemia. Zhong Guo You Sheng Yu Yi Chuan Za Zhi. 2008;16(2):39-40.
33. Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, Polychronopoulou S, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83(4):334-42.
34. Howell WM, Turner SJ, Theaker JM, Bateman AC. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet. 2003;30(6):409-14. (Pubitemid 38019299)
35. Nikolova PN, Pawelec GP, Mihailova SM, Ivanova MI, Myhailova AP, Baltadjieva DN, et al. Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol Immunother. 2007;56(3):371-9. (Pubitemid 46035905)
36. Rizzato C, Canzian F, Rudnai P, Gurzau E, Stein A, Koppova K, et al. Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin. Carcinogenesis. 2011;32(12):1849-54.
37. Basturk B, Yavascaoglu I, Vuruskan H, Goral G, Oktay B, Oral HB. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine. 2005;30(1):41-5. (Pubitemid 40387354)
38. Omrani M, Bazargani S, Bageri M. Interlukin-10, interferon-(gamma) and tumor necrosis factor-(alpha) genes variation in prostate cancer and benign prostatic hyperplasia. Current Urology. 2008;2(4):175-80.
39. Ahirwar DK, Agrahari A, Mandhani A, Mittal RD. Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers. 2009;14(4):213-8.
40. Nieters A, Yuan JM, Sun CL, Zhang ZQ, Stoehlmacher J, Govindarajan S, et al. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer. 2005;103(4):740-8. (Pubitemid 40216402)
41. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005;42(4):505-10. (Pubitemid 40342929)
42. Teixeira AC, Mendes Jr CT, Marano LA, Deghaide NH, Secaf M, Elias Jr J, et al. Alleles and genotypes of polymorphisms of IL-18, TNF-alpha and IFN-gamma are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil. Hum Immunol. 2013;74(8):1024-9.
43. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer. Scand J Gastroenterol. 2007;42(5):628-32. (Pubitemid 46633818)
44. Fei B, Lv H, Chen Y, Yang J. Single nucleotide polymorphism of interferon-gamma gene +874 T/A in colorectal cancer. World Chin J Digestol. 2006;14(20):2022-5. (Pubitemid 44518818)
45. Du W, Ye W, Chen M, Li D, Jing X. Association research between polymorphism of IFN-gamma and IL-10, environmental risk factors, and susceptibility to esophageal cancer. Wei Sheng Yan Jiu. 2013;42(5):770-6.
46. Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma. Neoplasma. 2009;56(1):56-62.
47. Farhat K, Hassen E, Gabbouj S, Bouaouina N, Chouchane L. Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet. 2008;35(3):197-205. (Pubitemid 351678685)
48. Tai SH, Wei YS, Wang P, Zhou B, Ran P, Yang ZH, et al. Genetic polymorphisms of interferon-gamma and interleukin-8 in patients with nasopharyngeal carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban. 2007;38(5):862-5.
49. Colakogullari M, Ulukaya E, Yilmaztepe Oral A, Aymak F, Basturk B, Ursavas A, et al. The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct. 2008;26(3):283-90. (Pubitemid 351613166)
50. Mi YY, Yu QQ, Xu B, Zhang LF, Min ZC, Hua LX, et al. Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: a meta-analysis based on 17 case-control studies. Mol Biol Rep. 2011;38(7):4461-7.
51. Liu F, Li B, Wei YG, Chen X, Ma Y, Yan LN, et al. IFN-gamma +874 A/T polymorphism and cancer risk: an updated analysis based on 32 case-control studies. Cytokine. 2011;56(2):200-7.
52. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
53. Ge YZ, Wu R, Jia RP, Liu H, Yu P, Zhao Y, et al. Association between interferon gamma +874 T > A polymorphism and acute renal allograft rejection: evidence from published studies. Mol Biol Rep. 2013;40(10):6043-51.
54. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. (Pubitemid 37088507)
55. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-48.
56. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. (Pubitemid 17189972)
57. Wang BS, Liu Z, Xu WX, Sun SL. CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression. Tumour Biol. 2013;34(4):2357-66.
58. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005;24(9):1291-306. (Pubitemid 40585169)
59. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101.
60. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34. (Pubitemid 27387172)
61. Slattery ML, Lundgreen A, Bondurant KL, Wolff RK. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis. 2011;32(11):1660-7.